You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 26, 2024

CLINICAL TRIALS PROFILE FOR PERFLUOROHEXYLOCTANE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for perfluorohexyloctane

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00403702 ↗ Comparison High-Density Silicone Oils in Retinal Detachment Unknown status Asociación para Evitar la Ceguera en México Phase 2/Phase 3 2006-08-01 The purpose of the study is to compare the safety, intraocular adverse effects and the anatomic and functional outcome with two endotamponade silicone oil after a 3-month in complex inferior retinal re-detachments.
NCT03333057 ↗ Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) Completed Novaliq GmbH Phase 2 2018-01-03 This study will evaluate the efficacy, safety and tolerability of perfluorohexyloctane (NOV03) at two different dosing regimens compared to saline solution in subjects with Dry Eye Disease (DED).
NCT04139798 ↗ Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) Completed Bausch & Lomb Incorporated Phase 3 2020-07-20 This trial will evaluate the efficacy, safety, and tolerability of NOV03 ophthalmic solution in comparison to a saline control for the treatment of the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD).
NCT04139798 ↗ Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study) Completed Novaliq GmbH Phase 3 2020-07-20 This trial will evaluate the efficacy, safety, and tolerability of NOV03 ophthalmic solution in comparison to a saline control for the treatment of the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for perfluorohexyloctane

Condition Name

Condition Name for perfluorohexyloctane
Intervention Trials
Dry Eye Disease (DED) 3
Dry Eye 1
Dry Eye Disease 1
Dry Eye, Evaporative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for perfluorohexyloctane
Intervention Trials
Keratoconjunctivitis Sicca 4
Eye Diseases 4
Dry Eye Syndromes 4
Signs and Symptoms 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for perfluorohexyloctane

Trials by Country

Trials by Country for perfluorohexyloctane
Location Trials
United States 37
Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for perfluorohexyloctane
Location Trials
California 4
Tennessee 3
Missouri 3
Illinois 3
Florida 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for perfluorohexyloctane

Clinical Trial Phase

Clinical Trial Phase for perfluorohexyloctane
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2/Phase 3 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for perfluorohexyloctane
Clinical Trial Phase Trials
Completed 3
Unknown status 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for perfluorohexyloctane

Sponsor Name

Sponsor Name for perfluorohexyloctane
Sponsor Trials
Novaliq GmbH 3
Bausch & Lomb Incorporated 2
Asociación para Evitar la Ceguera en México 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for perfluorohexyloctane
Sponsor Trials
Industry 5
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.